FDA Approves Higher Dose Opioid Overdose Reversal Drug Kloxxado
High-dose overdose reversal nasal spray will launch later this year.
High-dose overdose reversal nasal spray will launch later this year.
Research team looks at a safer pain management option.
Although physicians are more readily able to prescribe buprenorphine, pharmacies are still refusing to dispense it.
Moody issues a default judgment against Endo in Tennessee case.
Special master sanctions Walmart in multidistrict opioid litigation case.
J&J and other drug makers prepare for trial against Santa Clara, Los Angeles, and Orange counties, and the city of Oakland.
University is studying maternal opioid use on developing infants.
EXPAREL maker files suit against journal, editor, and authors.
Endo Pharmaceuticals keep important evidence out of discovery.
Researchers find NFEPP treatment for irritable bowel does not come with adverse effects.